Cover Image

10 year old boy with Idiopathic CD4 lymphocytopenia (ICL) and Cervical node MDR-TB - A rare case report

VELKUMAR .

Abstract


Abstract : Idiopathic CD4 lymphocytopenia (ICL) is defined as CD4 count 300 cellsmm3 or a CD4 count that is 20 percent of the total T cell count on 2 occasions, with absence of HIV infection and absence of any defined immunodeficiency. We report a 10 year old boy who presented with complaints of multiple swellings with discharging sinus in the neck with history of ATT intake since the age of two and half years due to non resolution of swelling with sinus. Culture and sensitivity test for MTB was done and was diagnosed as Extra  pulmonary (cervical node) MDR-TB. In this child the CD4 counts at 6 months interval met CDC criteria for ICL (155 Cellsmm3 in Dec, 2010 and 147 cellsmm3 in May, 2011). Reversal of CD4CD8 ratio was present. Patient has no other opportunistic infection except for cervical node MDR-TB. To our best knowledge this is one of those rare cases in  paediatric age group which warrants a mention, not only   because of CD4 depletion and but also presence of extra     pulmonary (cervical node) MDR TB in a 10 year old boy. The child is now on Interferon and DOTS PLUS therapy and doing well.

Keyword :ICL, MDR-TB, ATT, CD4 count.

 


Full Text:

PDF

References


Disseminated tuberculosis in a patient with idiopathic CD4+ lymphocytopenia Rheumatology (Oxford) 2009 48:1329-1330.

Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection-­United States.Centers for Disease Control (CDC).WR Morb Mortal Wkly Rep. 1992;41(30):541.

Idiopathic CD4+T-lymphocytopenia terminating in Burkitt's lymphoma. Shimano S, Murata N,Tsuchiya JRinsho Ketsueki. 1997;38(7):599

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood July 15, 2008 vol. 112 no. 2 287-294.

Walker UA, Warnatz K Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol2006;18:389­395.

Cunningham-Rundles C, Murray HW, Smith JP. Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol 1999;116:322-325.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University